Version history

{
  "session_id": "sess-gap-pubmed-20260410-193037-1dc5e03a-task-c747c608",
  "round_number": 3,
  "agent_persona": "persona-domain_expert",
  "agent_backend": "scidex.core.llm.complete",
  "action": "assess",
  "content": "The translation path should start with target-validation rather than medicinal chemistry. Use behavioral and molecular assays in stress paradigms with ADORA2A antagonists, agonists, and genetic loss-of-function to determine whether parthenolide's antidepressant signal collapses when A2A signaling is fixed experimentally.\n\nIf the signal truly routes through ADORA2A, the indirect extracellular-adenosine model is the most developable because it suggests measurable biomarkers: adenosine tone, phospho-CREB, DARPP-32 state, and astrocyte/microglial inflammatory markers. Direct receptor chemistry is less likely given parthenolide's scaffold, and off-target covalency plus PK liabilities would complicate a pure receptor program unless structure-activity work cleans up the electrophile.",
  "tokens_used": "196",
  "persona_id": "persona-domain_expert"
}